Overview: Actos is the subject of yet another lawsuit alleging the Type 2 diabetes drug caused bladder cancer, Madison-St. Clair Record reports. Takeda Pharmaceuticals North America Inc., Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals LLC, Takeda San Diego Inc. and Takeda Pharmaceuticals International Inc. have been named as Defendants in a lawsuit filed on April 5th in St. Clair County Circuit Court.
- Another Actos bladder cancer lawsuit was filed over bladder cancer claims on April 5th in St. Clair County Circuit Court
- The lawsuit alleges that the manufacturers knew Actos could cause bladder cancer but failed to warn consumers
- Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiffs’ Steering Committee in the Actos MDL in Louisiana
Product: Actos (pioglitazone)
Manufacturer: Takeda Pharmaceutical
Side Effects & Complications
- Bladder cancer
- Heart attacks
- Congestive heart failure
Actos Bladder Cancer, Failure to Warn
According to Madison-St. Clair Record, the Plaintiff in the case is Harry Bryant. He and his co-plaintiffs allege that they started taking Actos (pioglitazone) after being prescribed the medication by their doctors. The diabetes drug is also sold under the brand names Actoplus Met, Actoplus Met XR and Duetact. The lawsuit alleges that due to sustained use of the drug, the Plaintiffs developed bladder and urinary problems, including bladder cancer. The suit alleges that the Defendants knew Actos could cause bladder cancer but failed to warn consumers. The Plaintiffs seek more than $1.75 million in damages for medical expenses and court costs.
Actos Litigation and MDL
The first Actos bladder cancer lawsuit has gone to trial in Los Angeles state court, where jurors are weighing the lawsuit of Plaintiff Jack Cooper. Like thousands of other lawsuits, he alleges that Actos caused his bladder cancer. A doctor has testified in the case, stating that Actos is mostly to blame for Cooper’s illness. Numerous cases have also been filed in federal court as part of the multidistrict litigation entitled In Re: Actos (Pioglitazone) Products Liability Litigation (MDL No. 6:11-md-2299). Judge Rebecca Doherty is presiding over the litigation. Jerrold S. Parker, founding partner of Parker Waichman LLP, serves on the Plaintiff’s Steering Committee.